At the end of the day, most of us are old enough (and ugly...

At the end of the day, most of us are old enough (and ugly enough) to know what time it is. If you've invested in biotech thinking you'd be an overnight millionaire, you're an idjit. BIT shareholders has paid the dues in research and alignment - 20 years in fact. That's about right in biotech circles, hence patents for biotech are extended a further five years over the 20.

In my assessment (dyor, this is just another opinion on the interwebs), and by a sprinkling of good favour, we are closer than we think for payday.

Hopefully, those that have left us already (Peter and Charles, RIP) are vindicated in their faith for Biotron and by extension, MM's capable hands.